Although anti-CD38-IFNα(att) provided potent anti-tumor activity in various MM cell lines and in human xenograft MM tumor models, it is not addressed whether it induces T cell/immune cell activation. This evidence concerns the gene IFNA2 and Miyoshi myopathy.